Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Exagen Inc. (Nasdaq: XGN) will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024, in Snowbird, Utah. Exagen's President and CEO, John Aballi, and CFO, Kamal Adawi, will hold one-on-one meetings with investors during the event.
01/30/2024 - 04:05 PM
CARLSBAD, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 13-14, 2024 in Snowbird, Utah. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will be participating in one-on-one meetings with investors during the event; meetings can be requested through BTIG.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.
For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).
Contact: Ryan Douglas Exagen Inc.ir@exagen.com 760.560.1525
When and where will the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference take place?
The conference will take place on February 13-14, 2024, in Snowbird, Utah.
Who will be participating in one-on-one meetings with investors during the event?
Exagen's President and CEO, John Aballi, and CFO, Kamal Adawi, will be participating in one-on-one meetings with investors.
How can investors request meetings with Exagen during the event?
Investors can request meetings with Exagen through BTIG.
XGN Rankings
#4255 Ranked by Stock Gains
XGN Stock Data
Industry
Dental Laboratories
Sector
Manufacturing
Tags
Health Services, Medical/Nursing Services, Manufacturing, Dental Laboratories
Country
US
City
Vista
About XGN
exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.